Home | Publications | Country | Europe (West) | United Kingdom place holder
place holder place holder

United Kingdom

Smoking Cessation Aids in the United Kingdom


Publication Date   December 2005
Publisher   Euromonitor International
Product Type   Report
Pages   41
ISBN Number   not applicable
Product Code   EUR539
Ask a question about this product?

Price £450.00

approximately: $777 | €571

Summary


This report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (1999-2004), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2009 illustrate how the market is set to change.

Product coverage: NRT gum, NRT patches, NRT inhalators, other

Data coverage: market sizes (historic and forecasts), company shares, brand shares

Why buy this report?
• Get a detailed picture of the smoking cessation aids industry
• Pinpoint growth sectors and trends and identify factors driving change
• Understand the competitive environment, the market’s major players and leading brands
• Use five-year forecasts to assess how the market is predicted to develop

Content


OTC healthcare in the United Kingdom


1. EXECUTIVE SUMMARY


2. OPERATING ENVIRONMENT

2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
Table 1 Retail Sales of Homoeopathy 1998-2003
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 2 Consumer Expenditure on Health Goods and Medical Services 1999-2004
2.11 Life Expectancy
Table 3 Life Expectancy at Birth 1999-2004

3. OTC HEALTHCARE SALES

3.1 Market Performance
Table 4 Sales of OTC Healthcare by Sector: Value 1999-2004
Table 5 Sales of OTC Healthcare by Sector: % Value Growth 1999-2004
3.2 Switches
Summary 1 OTC Healthcare Switches 2004-2005
3.3 Key Trends and Developments
3.4 Competitive Environment
Table 6 OTC Healthcare Company Shares 2001-2004
Table 7 OTC Healthcare Brand Shares 2001-2004
3.5 Leading Company Profiles – Bayer Plc
Summary 2 Bayer AG Operational Indicators 2004
Table 8 Bayer Plc Shares of OTC Healthcare by Subsector 2001-2004
3.6 Leading Company Profiles – Boots Healthcare International
Summary 3 Boots HealthCare International Operational Indicators 2005
Table 9 Crookes Healthcare Ltd Shares of OTC Healthcare by Subsector 2001-2004
Table 10 Boots Plc Shares of OTC Healthcare by Subsector 2001-2004
3.7 Leading Company Profiles – GlaxoSmithKline Plc
Summary 4 GlaxoSmithKline Operational Indicators 2004
Table 11 GlaxoSmithKline Plc Shares of OTC Healthcare by Subsector 2001-2004
3.8 Leading Company Profiles – Johnson & Johnson MSD Ltd
Summary 5 Johnson & Johnson Inc Operational Indicators 2004
Table 12 Johnson & Johnson MSD Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.9 Leading Company Profiles – Novartis Pharmaceuticals UK Ltd
Summary 6 Novartis AG Operational Indicators 2004
Table 13 Novartis Pharmaceuticals UK Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.10 Leading Company Profiles – Pfizer Consumer Healthcare Ltd
Summary 7 Pfizer Inc Operational Indicators 2004
Table 14 Pfizer Consumer Healthcare Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.11 Leading Company Profiles – Reckitt Benckiser Plc
Summary 8 Reckitt Benckiser UK Ltd Operational Indicators 2004
Table 15 Reckitt Benckiser Plc Shares of OTC Healthcare by Subsector 2001-2004
3.12 Leading Company Profiles – Roche Products Ltd
Summary 9 Roche Holding AG Operational Indicators 2004
Table 16 Roche Products Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.13 Leading Company Profiles – Seven Seas Ltd
Table 17 Seven Seas Ltd Shares of OTC Healthcare by Subsector 2001-2004
3.14 Leading Company Profiles – SSL International Plc
Table 18 SSL International Shares of OTC Healthcare by Subsector 2001-2004
3.15 Leading Company Profiles – Wyeth Consumer Healthcare
Summary 10 Wyeth Consumer Healthcare Operational Indicators 2004
Table 19 Wyeth Consumer Healthcare Shares of OTC Healthcare by Subsector 2001-2004
3.16 Emerging and Niche Companies
3.17 Retail Distribution
Table 20 Sales of OTC Healthcare by Distribution Format: % Analysis 1999/2004
Table 21 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2004
3.18 Retailer Activity and Private Label Trends
Table 22 Penetration of Private Label by Sector 2001-2004
3.19 Forecast Market Performance
Table 23 Forecast Sales of OTC Healthcare by Sector: Value 2004-2009
Table 24 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2004-2009

4. SMOKING CESSATION AIDS SALES

4.1 Number of Smokers
Table 25 Number of Smokers by Gender 1999-2004
4.2 Sector Performance
Table 26 Sales of Smoking Cessation Aids by Subsector: Value 1999-2004
Table 27 Sales of Smoking Cessation Aids by Subsector: % Value Growth 1999-2004
Table 28 Smoking Cessation Aids Company Shares 2001-2004
Table 29 Smoking Cessation Aids Brand Shares 2001-2004
Table 30 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2004-2009
Table 31 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2004-2009
4.3 New Product Developments
Summary 11 Smoking Cessation Aids: New Product Launches 2003-2004

5. DEFINITIONS